China Universal Asset Management Company’s Cabaletta Bio CABA Stock Holding History

China Universal Asset Management Company’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$80.7K	Buy	25,950 +8,867	+52%	+$29.2K	﹤0.01%	434
2026 Q1	$46K	Buy	17,083 +1,397	+9%	+$3.88K	﹤0.01%	461
2025 Q4	$34.4K	Buy	+15,686	New	+$38.9K	﹤0.01%	470
2024 Q4	–	Sell	-9,395	Closed	-$44.3K	–	502
2024 Q3	$44.3K	Buy	9,395 +3,724	+66%	+$21.5K	﹤0.01%	391
2024 Q2	$42.4K	Sell	5,671 -2,535	-31%	-$31.1K	0.01%	367
2024 Q1	$140K	Buy	8,206 +3,244	+65%	+$69.6K	0.02%	335
2023 Q4	$113K	Buy	+4,962	New	+$83.4K	0.02%	270
2022 Q4	–	Sell	-272	Closed	–	–	405
2022 Q3	$0	Buy	+272	New	+$328	﹤0.01%	441

Other funds holding CABA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

China Universal Asset Management Company's CABA Position: Q2 2026 in Review

China Universal Asset Management Company increased its Cabaletta Bio (CABA) stake by 52% in Q2 2026, buying an estimated $29.2K and bringing the position to 25,950 shares worth $80.7K. The position accounts for ﹤0.01% of the portfolio, ranked #434.

China Universal Asset Management Company first reported a position in CABA in Q3 2022 and has held it in 8 quarters since. The position peaked at $140K in Q1 2024. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

China Universal Asset Management Company held 25,950 shares of Cabaletta Bio worth $80.7K as of Q2 2026.
China Universal Asset Management Company bought 8,867 Cabaletta Bio shares in Q2 2026, an estimated $29.2K.
Cabaletta Bio made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #434 holding.
China Universal Asset Management Company first reported a position in Cabaletta Bio in Q3 2022 and has held it in 8 quarters since.
China Universal Asset Management Company's Cabaletta Bio position peaked at $140K in Q1 2024.
139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.